We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Ben Park MD, PhD

Ben Ho Park MD, PhD

The Donna S. Hall Chair in Breast Cancer, Professor of Medicine, Vanderbilt University Medical Center, Co-Leader Breast Cancer Research Program, Associate Director for Translational Research, Director of Precision Oncology, Vanderbilt-Ingram Cancer Center, Nashville, TN
Dr. Park received his undergraduate degree with honors from the University of Chicago in 1989.  He then completed a dual M.D., Ph.D. training program at the University of Pennsylvania School of Medicine in 1995.  Dr. Park completed a residency in Internal Medicine and Hematology/Oncology Fellowship training at the Hospital of the University of Pennsylvania.  In 2001, Dr. Park finished a postdoctoral research fellowship in cancer genetics in the laboratory of Dr. Bert Vogelstein at Johns Hopkins.  In 2002, Dr. Park joined the faculty in the Department of Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.


Dr. Park has financial relationships with commercial entities that are relevant to the content of this presentation.

  • Royalties from Horizon Discovery, LTD
  • Scientific Advisory Board Member for Loxo Oncology
  • Ownership interest in Loxo Oncology
  • Consultant for Foundation Medicine, Inc.
  • Consultant for Jackson Laboratory
  • Consultant for H3 Biomedicine
  • Consultant for Casdin Capital